Alterity Therapeutics (PRNAD) Change in Cash (2009 - 2019)

Alterity Therapeutics (PRNAD) has reported Change in Cash for 5 consecutive years, with -$1.6 million the latest figure, recorded in Q4 2019.

• In Q4 2019, Change in Cash rose 68.41% year-over-year to -$1.6 million; the TTM figure through Dec 2019 stood at -$8.2 million (down 70.67% YoY), while the FY2025 annual figure was $13.3 million, up 692.99% from the prior year.
• Change in Cash came in at -$1.6 million for Q4 2019 at Alterity Therapeutics, up from -$5.1 million in the prior quarter.
• The five-year high for Change in Cash was -$598231.8 in Q4 2016, with the low at -$5.1 million in Q4 2018.
• Average Change in Cash over 4 years is -$2.1 million, with a median of -$1.3 million recorded in 2017.
• Across the five-year window, Change in Cash plunged 444.27% in 2018 and soared 68.41% in 2019, its largest moves.
• Year by year, Change in Cash stood at -$598231.8 in 2016, then sank by 56.04% to -$933486.7 in 2017, then slumped by 444.27% to -$5.1 million in 2018, then jumped by 68.41% to -$1.6 million in 2019.
• According to Business Quant data, Change in Cash over the past three periods registered -$1.6 million, -$5.1 million, and -$933486.7 for Q4 2019, Q4 2018, and Q4 2017 respectively.